Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia
AchievementWe are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib
_(4).png)
Pi Pharma Team Attended to "Market Sizing, Business Plan Development and Valuation" Training, Delivered By a Prominent Trainers From EY.
Aug, 2023
Pi Pharma Team Attended to "Market Sizing, Business Plan Development and Valuation" Training, Delivered By a Prominent Trainers From EY.
Breast Cancer Awareness at Pi Pharma Intelligence
Oct, 2025
At Pi Pharma Intelligence, we believe that awareness saves lives.
Pi Pharma Intelligence participate in the first ecosystem retreat in Jordan
May, 2023
Pi Pharma Intelligence participate in the first ecosystem retreat in Jordan